| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/24/2004 | US20040122214 Glycoprotein conjugate for the prevention lymphadenopathy associated viral infection; viricides |
| 06/24/2004 | US20040122213 Chlamydia heat shock protein |
| 06/24/2004 | US20040122212 Comprises attenuated bacterial mutant for use in designing drugs which prevent microbial infection; microbiocides |
| 06/24/2004 | US20040122211 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/24/2004 | US20040122210 exerts a trophic effects on the small and large intestine via stimulation of cell proliferation and inhibition of apoptosis |
| 06/24/2004 | US20040122209 Products for regulating the degradation of collagen and methods for identifying same |
| 06/24/2004 | US20040122013 Analogs of nocicettin |
| 06/24/2004 | US20040121976 Anti-inflammatory vectors |
| 06/24/2004 | US20040121960 For therapy of Alzheimer's and prion disease |
| 06/24/2004 | US20040121959 Comprises cyclic amino acid sequences for use in treatment and prevention of nervous system, inflammatory, pain, asthmatic, urogenital, skin and cancer disorders |
| 06/24/2004 | US20040121958 Methods of alleviating neuropathic pain |
| 06/24/2004 | US20040121957 For therapy of cystic fibrosis |
| 06/24/2004 | US20040121956 For therapy of diseases in animals and for the control of insects that are injurious or harmful to plants or animals |
| 06/24/2004 | US20040121954 Poly(dipeptide) as a drug carrier |
| 06/24/2004 | US20040121953 Thrombopoiesis-stimulating proteins having reduced immunogenicity |
| 06/24/2004 | US20040121949 For preparation of food additives or supplements in the medical field, as a source of easily assimilable amino acids useful for trophism of the osteo-articular system, scalp, nails and other particular tissues |
| 06/24/2004 | US20040121948 Methods and materials relating to semaphorin-like polypeptides and polynucleotides |
| 06/24/2004 | US20040121947 Compounds which inhibit beta-secretase activity and methods of use thereof |
| 06/24/2004 | US20040121946 For producing vaccines; therapy and prophylaxis of cancer |
| 06/24/2004 | US20040121940 Anticancer prodrugs, enhance enzymatic activation rates |
| 06/24/2004 | US20040121466 Alphavirus RNA replicon systems |
| 06/24/2004 | US20040121465 Optimization of gene sequences of virus-like particles for expression in insect cells |
| 06/24/2004 | US20040121463 Methods and compositions for modulating apoptosis |
| 06/24/2004 | US20040121443 Modified protamine with reduced immunogenicity |
| 06/24/2004 | US20040121440 Comprises nucleotide sequences coding 5' adenylyl phosphosulphate reductase for transformation and propagation of plants with decreased sulfur limitations; enhanced nutrient quality of animal feeds |
| 06/24/2004 | US20040121438 Comprises nucleotide sequences coding matrix metalloprotease enzyme inhibitors for use in the treatment of injuries; wound healing agents |
| 06/24/2004 | US20040121433 P153 and P156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof |
| 06/24/2004 | US20040121429 Comprises polypeptide with angiotensin converting enzyme activity for us in identifying modulators for treatment of cardiovascular, arthrosclerotic and hypertensive disorders |
| 06/24/2004 | US20040121412 Beta secretase exosite binding peptides and methods for identifying beta secretase modulators |
| 06/24/2004 | US20040121411 for monitoring cleavage of beta-amyloid precursor protein (beta APP) by monitoring the fluorescent energy transfer between the adducts; for treating Alzheimer's disease |
| 06/24/2004 | US20040121410 Comprises nucleotide sequences coding g protein-coupled receptor associated with nociceptive sensory neuron perception of injury; identifying modulators for treatment of chronic pain |
| 06/24/2004 | US20040121403 Detection and identification of groups of bacteria |
| 06/24/2004 | US20040121400 Method and kit for detecting, or determining, 3,4-methylenedioxymethamphetamine |
| 06/24/2004 | US20040121397 Using prostate tissue messenger RNA to detect, diagnose, classify, monitor, prognosticate, prevent or treat cell proliferative disorders of urogenital system |
| 06/24/2004 | US20040121396 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 06/24/2004 | US20040121393 Using allelic variance in immune response receptors to diagnose and prognose cancer, viral and bacterial infections, glomerulonephritis, sjogren's syndrome and leprosy |
| 06/24/2004 | US20040121389 Novel genes and methods that modulate apoptosis |
| 06/24/2004 | US20040121388 Murine cytokine receptor |
| 06/24/2004 | US20040121387 Comprises nucleotide sequences coding caspase 8 inhibitory protein for use in the treatment of alzheimer's, parkinson's, arthritic, septic, cardiovascular, inflammatory, osteoporotic and ischemic reperfusion injuries/disorders |
| 06/24/2004 | US20040121384 Identifying defects in protein tyrosine phosphatase gene and diagnosing and treating leukemic blood disorder |
| 06/24/2004 | US20040121380 Novel polypeptides and nucleic acids encoding same |
| 06/24/2004 | US20040121372 Comprises receptors for advanced glycation endproduct polypeptides for use in diagnosis and treatment inflammation, infection, sepsis, autoimmune, atherosclerotic and nervous system disorders |
| 06/24/2004 | US20040121370 Novel composition and methods for the treatment of immune related diseases |
| 06/24/2004 | US20040121368 having genetic aptitudes beneficial to people such as seeing-eye dogs, disaster rescue dogs, assisting dogs, narcotics detection dogs, watchdogs, and pet dogs; kits |
| 06/24/2004 | US20040121363 Novel variants of rankl protein |
| 06/24/2004 | US20040121362 for drug screening following exposure of cells to cigarette smoke; for the treatment of related disorders and conditions such as emphysema and chronic bronchitis |
| 06/24/2004 | US20040121361 Nucleic acid-associated proteins |
| 06/24/2004 | US20040121355 Estrogen receptor genes and utilization thereof |
| 06/24/2004 | US20040121351 for diagnosing polymorphism in a tubulin molecule and for anticancer drug screening |
| 06/24/2004 | US20040121341 Inhibitors of myelin-associated glycoprotein (MAG) activity for regulating neural growth and regeneration |
| 06/24/2004 | US20040121330 for treating, diagnosing, preventing, and screening for neurological, cardiovascular, and prostate, colon, breast, or lung- related conditions or disorders; genetic engineering |
| 06/24/2004 | US20040121327 Method for the prediction of the risk potential for cancerous diseases and inflammatory intestinal diseases and corresponding tests |
| 06/24/2004 | US20040121326 Neuregulin-4; for treating or preventing a disease, condition or syndrome associated with disregulation of an endogenous protein affecting receptor activity |
| 06/24/2004 | US20040121325 Beta 1,2-xylosyltransferase-gene from arabidopsis |
| 06/24/2004 | US20040121323 Mrna binding motif |
| 06/24/2004 | US20040121322 Comparative mycobacterial genomics as a tool for identifying targets for the diagnosis, prophylaxis or treatment of mycobacterioses |
| 06/24/2004 | US20040121317 HIV envelopolype peptides |
| 06/24/2004 | US20040121308 for producing the vectors and suppressing replication/reducing cytotoxicity of vector genome |
| 06/24/2004 | US20040121301 Agent imparting resistance to external stimuli |
| 06/24/2004 | US20040120969 The pure isolate does not suffer from the disadvantages of potential batch to batch variation between substrains and provides a product which is easier to ensure will meet consistent quality guidelines |
| 06/24/2004 | US20040120968 Methods for regulating bud-hypha transitions and cAMP levels in Candida albicans |
| 06/24/2004 | US20040120967 Use of L-carnitine for the treatment of cataract of non diabetic origin due to altered chaperone proteins by stabilizing the protein activity |
| 06/24/2004 | US20040120966 polypeptide comprises a C domain identical to a polypeptide that is a competitive inhibitor of bacterial adhesion of pneumococcal |
| 06/24/2004 | US20040120964 Needleless vaccination using chimeric yellow fever vaccine-vectored vaccines against heterologous flaviviruses |
| 06/24/2004 | US20040120961 Saposin C and receptors as targets for treatment of benign and malignant disorders |
| 06/24/2004 | US20040120957 Use of A33 antigens JAM-it |
| 06/24/2004 | US20040120956 CNGH0004 polypeptides, antibodies, compositions, methods and uses |
| 06/24/2004 | US20040120955 D1-1 nucleic acids, polypeptides and related methods |
| 06/24/2004 | US20040120951 Human-type anti-blood coagulation factor viii antibody |
| 06/24/2004 | US20040120946 capable of efficient and selective adsorption of an antibody against beta 1-adrenoceptor and/or an antibody against M2 muscarinic receptor occurring in a body fluid (e.g. blood, plasma or the like) without requiring a pretreatment |
| 06/24/2004 | US20040120945 Cell surface molecule mediating cell adhesion and signal transmission |
| 06/24/2004 | US20040120933 Pax-encoding vector and use thereof |
| 06/24/2004 | US20040120929 Defective lentivirus pseudotyped with a lyssavirus envelope; selective transfer of genes into astrocytes of central nervous system; nervous system and brain disorders; viral diseases |
| 06/24/2004 | US20040120910 Methods for producing, films comprising, and methods for using heterogeneous crosslinked protein networks |
| 06/24/2004 | US20040120899 Methods of treating allergy by administering interleukin-17 receptor |
| 06/24/2004 | US20040120898 Methods of treating asthma by administering interleukin-17 receptor |
| 06/24/2004 | DE10260633A1 New isolated nucleic acid encoding the human myosin heavy chain protein MYH14, useful for identifying mutations or alterations in nucleic acid, derived from chromosome 19q 13.3 |
| 06/24/2004 | CA2511775A1 Hla-a1,-a2 -a3,-a24,-b7,and -b44 tumor associated antigen peptides and compositions |
| 06/24/2004 | CA2509387A1 Peptide oligomers for use as hiv vaccines |
| 06/24/2004 | CA2509374A1 Glycogen synthase kinase-3 inhibitors |
| 06/24/2004 | CA2509373A1 Fluorescent proteins from aquatic species |
| 06/24/2004 | CA2509197A1 Plasmodium falciparum antigens and methods of use |
| 06/24/2004 | CA2508912A1 Oral lactoferrin in the treatment of sepsis |
| 06/24/2004 | CA2508848A1 Human pellino polypeptides |
| 06/24/2004 | CA2508847A1 Central nervous system damage |
| 06/24/2004 | CA2508773A1 Canine rankl and methods for preparing and using the same |
| 06/24/2004 | CA2508697A1 Non-human mutant mammals deficient in sigma receptors and their applications |
| 06/24/2004 | CA2508632A1 Dec-205 (ly 75) / dcl-1 intergenic splice variants associated with hodgkin's disease, and uses thereof |
| 06/24/2004 | CA2508631A1 Regulatory zinc finger proteins |
| 06/24/2004 | CA2508348A1 Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapy |
| 06/24/2004 | CA2508346A1 Mitoneet polypeptide from mitochondrial membranes, modulators thereof, and methods of using the same |
| 06/24/2004 | CA2507980A1 Pharmaceutical compositions preparation of peptides, secreted by the snake venom glands |
| 06/24/2004 | CA2507554A1 Midkine-like protein |
| 06/24/2004 | CA2507156A1 Methods of therapy and diagnosis using targeting of cells that express lax |
| 06/24/2004 | CA2505870A1 Targeting single epitopes |
| 06/23/2004 | EP1431391A2 Rantes mutants and therapeutic applications thereof |
| 06/23/2004 | EP1431310A1 RECOMBINANT ANTI−OSTEOPONTIN ANTIBODY AND USE THEREOF |
| 06/23/2004 | EP1431309A1 Colon specific genes and proteins |
| 06/23/2004 | EP1431308A1 Enzyme phosphorylating ser46 of p53 |
| 06/23/2004 | EP1431307A1 Inactive transcription factor TIF-IA and uses thereof |